Cargando…
Doxorubicin inhibits osteosarcoma progression by regulating circ_0000006/miR-646/ BDNF axis
BACKGROUND: Osteosarcoma (OS) is the most common aggressive bone tumor in children and teenagers. Doxorubicin (DOX) is a chemotherapeutic drug for OS. This study aims to reveal the effects and underneath mechanism of DOX treatment in OS progression. METHODS: The expression of circular_0000006 (circ_...
Autores principales: | Amuti, Abulimiti, Liu, Dehu, Maimaiti, Ayiguli, Yu, Yao, Yasen, Yalikun, Ma, Haoguang, Li, Rui, Deng, Shurong, Pang, Fei, Tian, Youliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557021/ https://www.ncbi.nlm.nih.gov/pubmed/34717683 http://dx.doi.org/10.1186/s13018-021-02782-y |
Ejemplares similares
-
Circ_0000527 promotes osteosarcoma cell progression through modulating miR-646/ARL2 axis
por: Wu, Xiangkun, et al.
Publicado: (2021) -
hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma
por: Gao, Yang, et al.
Publicado: (2021) -
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis
por: Zhang, Li, et al.
Publicado: (2020) -
Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis
por: Guan, Huapeng, et al.
Publicado: (2021) -
Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis
por: Bai, Yumei, et al.
Publicado: (2021)